tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Income Statement

Compare
311 Followers

Mineralys Therapeutics, Inc. Income Statement

Last quarter (Q4 2024), Mineralys Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Mineralys Therapeutics, Inc.'s net income was $-48.95M. See Mineralys Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 192.40M$ 84.66M$ 31.48M$ 18.73M$ 2.94M
Depreciation and Amortization
$ 0.00$ 0.00$ 228.49K$ 18.73M$ 2.94M
EBITDA
$ -192.40M$ -84.66M$ -31.48M$ 0.00$ 0.00
Operating Income
$ -192.40M$ -84.66M$ -31.48M$ -18.73M$ -2.94M
Other Income/Expenses
$ 14.59M$ 12.76M$ 1.68M$ -683.00K$ -483.00K
Pretax Income
$ -177.81M$ -71.90M$ -29.80M$ -19.41M$ -3.43M
Net Income
$ -177.81M$ -71.90M$ -29.80M$ -19.41M$ -3.43M
Per Share Metrics
Basic EPS
$ -3.66$ -1.99$ -0.73$ -0.50$ -0.09
Diluted EPS
$ -3.66$ -1.99$ -0.73$ -0.50$ -0.09
Weighted Average Shares Outstanding
48.54M 36.19M 40.86M 39.06M 39.06M
Weighted Average Shares Outstanding (Diluted)
48.54M 36.19M 40.86M 39.06M 39.06M
Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis